Viatris (VTRS) FCF Payout Ratio (QoQ) (2021 - 2026)
Powered by 
Analysis
Viatris (VTRS) FCF Payout Ratio (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.05% |
| Mar 31, 2026 | 79.56% |
| Dec 31, 2025 | 4.97% |
| Sep 30, 2025 | -74.64% |
| Jun 30, 2025 | 188.29% |
| Mar 31, 2025 | -30.55% |
| Dec 31, 2024 | 119.11% |
| Sep 30, 2024 | -57.94% |
| Jun 30, 2024 | 79.67% |
| Mar 31, 2024 | -29.24% |
| Dec 31, 2023 | 83.58% |
| Sep 30, 2023 | -38.14% |
| Jun 30, 2023 | 102.06% |
| Mar 31, 2023 | -96.22% |
| Dec 31, 2022 | 2,067.42% |
| Sep 30, 2022 | -6.08% |
| Jun 30, 2022 | 49.87% |
| Mar 31, 2022 | -66.92% |
| Dec 31, 2021 | 196.16% |
| Sep 30, 2021 | -51.26% |